Delivery Order SPE2DR25D1017-SPE2DR26F9AUX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,451.73 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $23,573.76 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3,...
- The Defense Logistics Agency awarded a $7,046.61 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on May 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 27, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,317.77 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 and extends through December 2026. The product will be delivered to AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $10,999.90 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,856.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 12, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $5,579.73 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the vendor's corporate headquarters...
- The Defense Logistics Agency awarded a $1,501.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AUXDelivery Order
The Defense Logistics Agency awarded a $1,769.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of products across multiple therapeutic domains to support military healthcare programs worldwide. Trulicity is a diabetes medication included within the company's extensive federal contract portfolio, which demonstrates AmerisourceBergen's capability to meet diverse federal medical supply requirements through open competition and established prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/3/25 |